Article Information
History
- December 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, USA
- 2Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, USA
- ↵*Corresponding Author:
Hong Yang, Ph.D., Hong.Yang{at}fda.hhs.gov
Posted December 01, 2022.
Modeling and Simulation of CAR T cell Therapy in Chronic Lymphocytic Leukemia Patients
